GO2 for Lung Cancer, Dana-Farber Cancer Institute, and Addario Lung Cancer Medical Institute Announce Expansion of Landmark Patient Research on Underlying Causes of Inherited Risk of Lung Cancer

2024-04-17T09:08:46-05:00April 17th, 2024|Hot Topics, News, Press Releases, Science and Research|

Clinical Trial Aims to Unlock the Origins of Lung Cancer   WASHINGTON and BOSTON, April 17, 2024 – In a promising step forward, GO2 for Lung Cancer (GO2), Dana-Farber Cancer Institute (Dana-Farber), and the Addario Lung Cancer Medical Institute (ALCMI), [...]

New Study to Address Cancer Treatment Resistance for People Who Are KRAS Positive

2022-11-30T09:45:01-06:00November 30th, 2022|Hot Topics, News, Science and Research|

SAN CARLOS, Calif., (November 30, 2022) – The Addario Lung Cancer Medical Institute (ALCMI), a patient-founded not-for-profit global research consortium, has launched the SPARK Study to help researchers better understand treatment resistance in patients with KRAS-positive lung cancer and [...]

Go to Top